Operational revenue from Pfizer’s Covid vaccine Comirnaty and Paxlovid pill to treat the illness declined 59% and 63%, ...
8hon MSN
Pfizer didn't say hantavirus is side effect of its COVID-19 vaccine, contrary to online claims
Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.
By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer said on Tuesday that it expects to return to stronger growth ...
Higher sales of cancer treatments helped fuel better-than-expected first-quarter sales and profit for the drugmaker.
CRANBURY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- OncLive ®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum supporter), Daiichi-Sankyo (platinum supporter) and ...
Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, ...
Pfizer is looking to newer products and acquisitions to offset a declining Covid business.
1don MSN
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics
Is Pfizer a yield trap? No way.
Pfizer’s first-quarter results gave investors a clearer view of how much work the drugmaker’s newer portfolio is doing as the ...
Veppanu, the first PROTAC therapy approved by the FDA, improved progression free survival by 43% versus AstraZeneca’s ...
Despite the continued decline of Pfizer's COVID-19 products, shares stayed stable on Tuesday morning after the New York ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results